Affiliation:
1. Research Center of Neurology
Abstract
In Parkinson’s disease (PD), some structural changes in the retina have been shown using optical coherence tomography (OCT). Among them most attractive are atrophic changes in retinal nerve fi ber layer (RNFL). However, diagnostic signifi cance of the OCT method in PD remains debatable. Objective: to investigate a thickness of RNFL in Parkinson’s disease patients and to determine the signifi cance of the OCT method in the PD diagnostics. Materials and methods. In PD patients (n = 24) and in a control group (n = 20) OCT was used to study the thickness of RNFL — average, in quadrants and in 10 sectors. Results. In patients with PD thinning of RNFL in the inferior quadrant was revealed (p = 0.009). The sensitivity and specifi city of the method were 56% and 82%, respectively. The thickness of RNFL was not associated with parkinsonian symptoms asymmetry, duration and severity of the disease. In the control group and in PD patients, there was a relationship between the RNFL thickness and age. Conclusion. PD is characterized by atrophic changes in the retina in the form of thinning of RNFL in the inferior quadrant, which confi rms the systemic nature of neurodegenerative pathology in this disease going beyond the substantia nigra and brain tissue. At the same time, the thickness of RNFL showed limited diagnostic value for detecting PD cases.
Publisher
Medical Informational Agency Publishers
Subject
Psychiatry and Mental health,Neurology (clinical),Neurology
Reference27 articles.
1. Nguyen-Legros J. Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson’s disease. Surg Radiol Anat. 1988;10(2):137–144. https://doi.org/10.1007/BF02307822
2. Bodis-Wollner I., Kozlowski P.B., Glazman S., Miri S. α-synuclein in the inner retina in parkinson disease. Ann Neurol. 2014;75(6):964–966. https://doi.org/10.1002/ana.24182
3. Beach T.G., Carew J., Serrano G., Adler C.H., Shill H.A., Sue L.I., Sabbagh M.N., Akiyama H., Cuenca N. Arizona Parkinson’s Disease Consortium. Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson’s disease subjects. Neurosci Lett. 2014;571:34–38. https://doi.org/10.1016/j.neulet.2014.04.027
4. Devos D., Tir M., Maurage C.A., Waucquier N., Defebvre L., Defoort-Dhellemmes S., Destée A. ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies. Neurology. 2005;65(7):1107–1110. https://doi.org/10.1212/01. wnl.0000178896.44905.33
5. Litvinenko I.V., Boyko E.V., Kulikov A.N., Dynin P.S., Trufanov A.G., Maltsev D.S., Yurin A.A. The relationship between visuospatial disorders in Parkinson’s disease and thickness of retina and cortex. Annals of Clinical and Experimental Neurology. 2016;10(2):11–16. (Russian). https://doi.org/10.17816/ psaic66